BioNTech SE
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Val T. HoyleHouse · D · OR |
BNTXBioNTech SE · Stock |
Sale $1,001 - $15,000 |
Sep 12, 2025 | Aug 7, 2025 | Filing ↗ |
Josh GottheimerHouse · D · NJ |
BNTXBioNTech SE · Stock |
Sale $1,001 - $15,000 |
Oct 3, 2024 | Sep 3, 2024 | Filing ↗ |
Josh GottheimerHouse · D · NJ |
BNTXBioNTech SE · Stock |
Sale $1,001 - $15,000 |
Sep 11, 2024 | Aug 30, 2024 | Filing ↗ |
Josh GottheimerHouse · D · NJ |
BNTXBioNTech SE · Stock |
Purchase $1,001 - $15,000 |
May 15, 2024 | Apr 15, 2024 | Filing ↗ |
Josh GottheimerHouse · D · NJ |
BNTXBioNTech SE · Stock |
Sale $1,001 - $15,000 |
Apr 7, 2024 | Mar 14, 2024 | Filing ↗ |
Josh GottheimerHouse · D · NJ |
BNTXBioNTech SE · Stock |
Purchase $1,001 - $15,000 |
Jan 7, 2024 | Dec 6, 2023 | Filing ↗ |
Josh GottheimerHouse · D · NJ |
BNTXBioNTech SE · Stock |
Purchase $1,001 - $15,000 |
Jan 7, 2024 | Dec 5, 2023 | Filing ↗ |
Josh GottheimerHouse · D · NJ |
BNTXBioNTech SE · Stock |
Purchase $1,001 - $15,000 |
Jan 7, 2024 | Dec 7, 2023 | Filing ↗ |
Whale Activity
- Increased90
- New55
- Held59
- Decreased86
- Closed33
- No prior filing13
| Filer | Shares | Value | Change |
|---|---|---|---|
| FMR LLC | 9.8M | $963.1M | increased |
| PRIMECAP MANAGEMENT CO/CA/ | 3.8M | $368.9M | decreased |
| DODGE & COX | 3.7M | $362.5M | increased |
| BlackRock, Inc. | 1.8M | $180.4M | decreased |
| BNP PARIBAS FINANCIAL MARKETS | 1.3M | $126.0M | decreased |
| T. Rowe Price Investment Management, Inc. | 1.2M | $121.9M | decreased |
| Temasek Holdings (Private) Ltd | 1.2M | $121.5M | decreased |
| FIRST TRUST ADVISORS LP | 996.3K | $97.9M | increased |
| D. E. Shaw & Co., Inc. | 974.9K | $95.8M | increased |
| GOLDMAN SACHS GROUP INC | 863.7K | $84.9M | increased |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 800.9K | $78.7M | increased |
| Assenagon Asset Management S.A. | 760.7K | $74.8M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Sahin UgurChief Executive Officer | Sale | −36.2K | $95.37 | $3.5M | Oct 9, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer | Sale | −27.0K | $92.31 | $2.5M | Oct 8, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer | Sale | −24.0K | $95.86 | $2.3M | Oct 7, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer | Sale | −21.0K | $96.81 | $2.0M | Oct 6, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer | Sale | −72.0K | $97.23 | $7.0M | Oct 5, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer | Sale | −17.0K | $96.72 | $1.6M | Oct 2, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer | Sale | −17.0K | $97.46 | $1.7M | Oct 1, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −32.0K | $98.12 | $3.1M | Sep 30, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −34.0K | $98.26 | $3.3M | Sep 29, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −34.0K | $98.47 | $3.3M | Sep 28, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −27.0K | $98.69 | $2.7M | Sep 25, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −39.0K | $98.99 | $3.9M | Sep 24, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −30.0K | $99.40 | $3.0M | Sep 23, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −46.0K | $100.72 | $4.6M | Sep 22, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −33.0K | $97.81 | $3.2M | Sep 21, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −30.0K | $96.22 | $2.9M | Sep 18, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −34.0K | $98.60 | $3.4M | Sep 17, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −15.0K | $96.09 | $1.4M | Sep 16, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −34.0K | $96.49 | $3.3M | Sep 15, 2026 | Form 4 ↗ |
| Sahin UgurChief Executive Officer · 10% owner | Sale | −41.0K | $99.45 | $4.1M | Sep 14, 2026 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Fidelity Contrafund | 3.3M | $305.0M | 0.17% | Jun 30, 2026 |
| Dodge & Cox International Stock Fund Dodge & Cox Funds | 2.5M | $234.3M | 0.35% | Jun 30, 2026 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 1.0M | $94.8M | 0.41% | Jun 30, 2026 |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 897.2K | $81.3M | 1.10% | Jul 31, 2026 |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 794.7K | $73.9M | 2.63% | Jun 30, 2026 |
| Fidelity Contrafund K6 Fidelity Contrafund | 704.5K | $65.6M | 0.17% | Jun 30, 2026 |
| iShares Biotechnology ETF iShares Trust | 647.1K | $60.2M | 0.66% | Jun 30, 2026 |
| Fidelity Emerging Markets Fund Fidelity Investment Trust | 660.8K | $59.9M | 0.55% | Jul 31, 2026 |
| Dodge & Cox Global Stock Fund Dodge & Cox Funds | 525.8K | $48.9M | 0.38% | Jun 30, 2026 |
| MFS Mid Cap Value Fund MFS SERIES TRUST XI | 487.2K | $45.3M | 0.26% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list BNTX's shares (CUSIP 09075V102), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Corporate Lobbying
No lobbying filings found naming BioNTech SE as the client.
Government Contracts
No federal contract awards found for BioNTech SE.
U.S. Patents
No USPTO patent applications found for BioNTech SE.
Annual Financials
SEC's XBRL figures for BioNTech SE include no full-year results from a 10-K in US dollars, so there is no table to show. Companies based abroad usually report annually on Form 20-F instead.
Stock Splits
No stock splits in BNTX's price history.
Material Events (8-K)
No 8-K filings on record.


